The largest ever clinical trial of T cell therapy (a type of cell-based immunotherapy) for solid tumours has been completed. Led by a Singapore clinician-investigator, the global, international, ...

The largest ever clinical trial of T cell therapy for solid tumours has ended, heralding a new era for precision T cell ...

OncoSil Medical Ltd (AU:OSL) has released an update. OncoSil Medical Ltd has achieved a significant milestone with the ...

Goldman Sachs has upgraded BioNTech SE (NASDAQ:BNTX), citing the company’s BNT327, an immuno-oncology asset in clinical ...

From cutting-edge treatment methods to the integration of new technologies, the International Conference on Advances in Radiation Oncology (ICARO-4) promises to inspire and equip conference attendees ...

Additionally, positive findings from trials like ADRIATIC (NCT03703297) and IMforte (NCT05091567) are further shaping ...

The global sales of central venous catheters (CVC) are estimated to be valued at USD 2,861.0 million in 2024 and are expected ...

Panelist discusses how the second interim overall survival data from MARIPOSA-2, presented at the European Society for ...

Evidence suggests that combining metformin with standard of care could increase survival and offer other benefits to patients with high-volume disease.

Co-authored by investigators of VHIO's Cancer Genomics Group and Research Unit for Molecular Therapy of Cancer (UITM) – CaixaResearch, results of a ...

Company Achieves Milestones in Both Clinical ProgramsInitiates Mipletamig Phase 1b/2 Clinical Trial, "RAINIER," in Frontline Acute Myeloid Leukemia, Informed by Positive Dose Escalation Trial ...